Stock 543363 PREVEST DENPRO LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Prevest Denpro Limited

Equities

543363

INE0GAO01018

Advanced Medical Equipment & Technology

Market Closed - Bombay S.E.
Other stock markets
 03:30:59 03/06/2024 pm IST 		5-day change 1st Jan Change
388.5 INR +1.64% Intraday chart for Prevest Denpro Limited -1.01% -7.06%
28/05 Prevest Denpro Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI
28/05 Prevest Denpro Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI

Valuation

Fiscal Period: March 2022 2023
Capitalization 1 4,333 3,339
Enterprise Value (EV) 1 3,916 2,937
P/E ratio 37.5 x 21.2 x
Yield - 0.36%
Capitalization / Revenue 11.4 x 6.7 x
EV / Revenue 10.3 x 5.89 x
EV / EBITDA 26 x 15 x
EV / FCF 65,98,30,834 x -5,39,62,573 x
FCF Yield 0% -0%
Price to Book 7.59 x 4.59 x
Nbr of stocks (in thousands) 12,003 12,003
Reference price 2 361.0 278.2
Announcement Date 24/08/22 05/08/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 173.9 194.3 229.9 286.5 381.1 498.5
EBITDA 1 33.56 39.84 63.87 91.59 150.6 196.1
EBIT 1 29.4 35.81 59.47 86.87 145.3 189.4
Operating Margin 16.91% 18.43% 25.87% 30.32% 38.13% 37.98%
Earnings before Tax (EBT) 1 29.26 37.56 62.77 93.35 160.5 209.6
Net income 1 21.71 29.94 50.22 72.07 115.7 157.1
Net margin 12.48% 15.41% 21.84% 25.15% 30.36% 31.51%
EPS 2 2.457 3.389 5.684 8.157 9.638 13.09
Free Cash Flow - 8.706 25.27 46.4 5.935 -54.42
FCF margin - 4.48% 10.99% 16.19% 1.56% -10.92%
FCF Conversion (EBITDA) - 21.85% 39.57% 50.67% 3.94% -
FCF Conversion (Net income) - 29.08% 50.33% 64.39% 5.13% -
Dividend per Share - - - - - 1.000
Announcement Date 06/05/21 06/05/21 06/05/21 24/08/22 24/08/22 05/08/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 30.2 47.2 88.8 155 417 402
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - 8.71 25.3 46.4 5.94 -54.4
ROE (net income / shareholders' equity) - 34% 39.2% 38.1% 29.1% 24.2%
ROA (Net income/ Total Assets) - 16.7% 20.4% 21% 19.2% 16.6%
Assets 1 - 179.6 246.2 343.6 604 947.5
Book Value Per Share 2 8.270 11.70 17.30 25.50 47.60 60.60
Cash Flow per Share 2 4.740 6.860 11.70 18.60 35.30 32.50
Capex 1 12.2 14 7.78 22.3 48.9 135
Capex / Sales 7.02% 7.19% 3.38% 7.79% 12.83% 27.13%
Announcement Date 06/05/21 06/05/21 06/05/21 24/08/22 24/08/22 05/08/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
PREVEST DENPRO LIMITED Stock Prevest Denpro Limited
-7.06% 54.98M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+6.68% 217B
DANAHER CORPORATION Stock Danaher Corporation
+11.95% 190B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+19.05% 143B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+30.12% 111B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+0.65% 64.59B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+14.91% 52.36B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+2.06% 48.45B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-5.09% 38.03B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
-0.74% 35.6B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. 543363 Stock
  4. Financials Prevest Denpro Limited